Table 1.

Prevalence of the ABCA1 1051G/A and −477C/T genotypes in 838 CAD patients and 257 controls and effect on HDL-C concentration.

GenotypeCAD patientsControls
n (%)HDL-C,1 mmol/Ln (%)HDL-C,1 mmol/L
1051GG450 (53.7)0.90 (0.01)2115 (44.7)1.23 (0.03)
1051GA327 (39.0)0.91 (0.01)2112 (43.6)1.24 (0.03)
1051AA61 (7.3)30.99 (0.03)230 (11.7)31.31 (0.06)
−477CC237 (28.3)0.90 (0.02)71 (27.6)1.29 (0.04)
−477CT426 (50.8)0.90 (0.01)133 (51.8)1.23 (0.03)
−477TT175 (20.9)0.94 (0.020)53 (20.6)1.21 (0.04)
  • 1 Values are the mean (SE) and are adjusted for age and sex.

  • 2 P <0.05 for 1051AA vs 1051GG and 1051GA in CAD group.

  • 3 P <0.05 for CAD patients vs controls.